Skip to main content

Table 1 Overview of studies reviewed

From: Protective socks for people with diabetes: a systematic review and narrative analysis

Study

Demographic data

Inclusion criteria (in addition to diabetes)

Findings

Blackwell et al. [34]

N° of subjects 21

Diabetes with foot complaints, no active ulceration

Plantar pressure assessed with Parotec system

Gender 10 M : 11 F

Mean age (range) 57.4 (20-83)

No significant difference between JBOST diabetic sock, normal sock or barefoot

Diabetes duration Not stated

Veves et al. [35]

N° of subjects 27

High plantar pressures (>10 kg/cm2)

Plantar pressure assessed with optical pedobarograph

Gender 15 M: 2 F

Neuropathy (diminished nerve conduction & vibration perception)

Experimental socks [Thorlo] provided significant pressure reduction compared with pts own socks or barefoot (both p < 0.001)

Mean age (range) 54 (26-74)

Diabetes duration not stated

Able walk unaided, no PVD, no ulcer history

Veves et al. [36]

Gender not stated

Neuropathy (diminished vibration perception & absent ankle reflex)

Plantar pressure assessed with optical pedobarograph

Experimental group (n = 10)

mean age (range) 51.3 (27-65)

Duration of diabetes not stated

Significant reduction in pressure of experimental socks [Thorlo] compared with padded sports socks & barefoot (all p < 0.001). Pressure reduction maintained by experimental socks at 3 & 6 months.

Control group n = 16

Mean age (range) 55.8 (33-70)

Garrow et al. [37]

N° of subjects 19

Neuropathy (neuropathy disability score >5 or diminished vibration perception ≥25).

Plantar pressure assessed with F-scan system

Gender 15 M:4 F

Mean age (range) 65.5 (39-80)

Ulcer-free at recruitment

Preventative Foot Care Diabetic socks provided significant increase in foot contact area (p < 0.01), a reduction total pressure (p < 0.01).

Diabetes duration median 20 yrs

High plantar pressure (≥6 kg/cm2).

Murray et al. [38]

N° of subjects 86

Neuropathy (diminished pressure or vibration perception)

Questionnaire based satisfaction survey over 6 month period using Thorlo socks

Gender 69 M :17 F

Mean age (range) 63 (34-85)

No active ulceration

Socks reported good/very good by 86%, average by 12% & poor by 3%.

Mean diabetes (range) 16 (1–45 yrs

84% reported continue sock use at 3 & 6 months

Banchellini et al. [39]

N° of subjects 30

Peripheral neuropathy (ADA criteria)

Skin parameters tested:

Gender not stated

Hydration (hydration score) Hardness (Durometer)

Group A (Difoprev) socks

Anhidrosis (Clinical features & Neuropad test)

Moisture loss (Scalar moisture checker)

Mean age 59.6 (SD13.8)

Water loss (TEWL vapometer)

Duration diabetes 16.1 (SD9)

No active ulceration, ABPI >0.9, Serum creatinine >2 mg/dL

All skin parmeters improved over 6 week trial (Difoprev) socks & normal socks

Group B (no active sock ingredient)

Mean age 61.4 (SD15.5)

Skin hydration p < 0.01 Skin hardness p <0.05

Duration diabetes 15.7 (SD6.9)

No systemic skin disease, no B-blocker therapy

Controls (normal socks)

Skin moisture loss p < 0.01 Skin water loss p < 0.01

Mean age 60.5 (SD11.4)

Yick et al. [40]

No of subjects 4

No inclusion criteria stated

Plantar pressure (Pedar system)

Gender not stated

Skin temperature & humidity (system not stated)

Age not stated

Socks tested not stated

Diabetes duration not stated

Considerable pressure reduction stated but not per sock type

Thermal properties are stated but not compared between socks or post sock wear